Clinical Trial Update: A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel [Phase 4]

View source ↗

Summary

A Phase 4 long-term follow-up trial for patients who were previously treated with cilta-cel (cilta-cabtagene autoleucel) for multiple myeloma is currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Ciltacabtagene autoleucel (cilta-cel)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Multiple Myeloma | Phase 4 | Status: RECRUITING